Nuklearmedizin - NuclearMedicine

LinksSchließen

Referenz

Zukotynski KA, Emmenegger U, Hotte S. et al.
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen (PSMA)-Targeted (18)F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or Enzalutamide.

J Nucl Med 2021;
62 (10) 1430-1437
DOI: 10.2967/jnumed.120.259069. (PMID: 33608426)

Bibliographische Angaben herunterladen

Aufrufen in: